Kiniksa Pharmaceuticals International, plc
Equities
KNSA
GB00BRXB0C07
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18 USD | -3.59% |
|
-4.61% | +2.62% |
07-01 | Kiniksa Pharmaceuticals Files $400 Million Mixed Shelf | MT |
06-26 | Sector Update: Health Care Stocks Mixed Pre-Bell Wednesday | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.62% | 1.28B | |
+15.82% | 122B | |
+20.35% | 114B | |
+18.31% | 25.71B | |
-25.31% | 19.02B | |
-20.84% | 15.83B | |
-19.67% | 15.32B | |
-46.87% | 14.88B | |
+62.55% | 14.82B | |
+6.34% | 14.1B |
- Stock Market
- Equities
- KNSA Stock
- News Kiniksa Pharmaceuticals International, plc
- Transcript : Kiniksa Pharmaceuticals, Ltd. Presents at 38th Annual J.P Morgan Healthcare Conference, Jan-13-2020 02